Tvardi Therapeutics, Stock Market Value
| TVRD Stock | 4.02 0.02 0.50% |
| Symbol | Tvardi |
Tvardi Therapeutics, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tvardi Therapeutics,. If investors know Tvardi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tvardi Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.25) |
The market value of Tvardi Therapeutics, is measured differently than its book value, which is the value of Tvardi that is recorded on the company's balance sheet. Investors also form their own opinion of Tvardi Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Tvardi Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tvardi Therapeutics,'s market value can be influenced by many factors that don't directly affect Tvardi Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tvardi Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Tvardi Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tvardi Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tvardi Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tvardi Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tvardi Therapeutics,.
| 06/28/2025 |
| 12/25/2025 |
If you would invest 0.00 in Tvardi Therapeutics, on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding Tvardi Therapeutics, or generate 0.0% return on investment in Tvardi Therapeutics, over 180 days. Tvardi Therapeutics, is related to or competes with CalciMedica, Common, Lantern Pharma, Actinium Pharmaceuticals, Elutia, PDS Biotechnology, Reviva Pharmaceuticals, and Xilio Development. Tvardi Therapeutics, is entity of United States More
Tvardi Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tvardi Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tvardi Therapeutics, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 91.61 | |||
| Value At Risk | (6.64) | |||
| Potential Upside | 5.61 |
Tvardi Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tvardi Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tvardi Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Tvardi Therapeutics, historical prices to predict the future Tvardi Therapeutics,'s volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.73) | |||
| Total Risk Alpha | (2.74) | |||
| Treynor Ratio | 1.02 |
Tvardi Therapeutics, Backtested Returns
Tvardi Therapeutics, owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the firm had a -0.17 % return per unit of risk over the last 3 months. Tvardi Therapeutics, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tvardi Therapeutics,'s Variance of 118.1, coefficient of variation of (595.60), and Risk Adjusted Performance of (0.11) to confirm the risk estimate we provide. The entity has a beta of -1.8, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Tvardi Therapeutics, are expected to decrease by larger amounts. On the other hand, during market turmoil, Tvardi Therapeutics, is expected to outperform it. At this point, Tvardi Therapeutics, has a negative expected return of -1.83%. Please make sure to validate Tvardi Therapeutics,'s treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Tvardi Therapeutics, performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.42 |
Modest reverse predictability
Tvardi Therapeutics, has modest reverse predictability. Overlapping area represents the amount of predictability between Tvardi Therapeutics, time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tvardi Therapeutics, price movement. The serial correlation of -0.42 indicates that just about 42.0% of current Tvardi Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.42 | |
| Spearman Rank Test | -0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 175.6 |
Tvardi Therapeutics, lagged returns against current returns
Autocorrelation, which is Tvardi Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tvardi Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Tvardi Therapeutics, returns to help us make a trade decision. For example, suppose you find that Tvardi Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tvardi Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tvardi Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tvardi Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tvardi Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Tvardi Therapeutics, Lagged Returns
When evaluating Tvardi Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tvardi Therapeutics, stock have on its future price. Tvardi Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tvardi Therapeutics, autocorrelation shows the relationship between Tvardi Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Tvardi Therapeutics,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tvardi Therapeutics, is a strong investment it is important to analyze Tvardi Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tvardi Therapeutics,'s future performance. For an informed investment choice regarding Tvardi Stock, refer to the following important reports:Check out Tvardi Therapeutics, Correlation, Tvardi Therapeutics, Volatility and Tvardi Therapeutics, Alpha and Beta module to complement your research on Tvardi Therapeutics,. For information on how to trade Tvardi Stock refer to our How to Trade Tvardi Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Tvardi Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.